U.S. Flow Cytometry Market Size, Share & Forecast to 2030

The U.S. flow cytometry market size is anticipated to reach USD 2.61 billion by 2030 and is growing at a CAGR of 6.8% from 2024 to 2030. The market for flow cytometry is expanding faster in the U.S. owing to increased cancer cases and other chronic illnesses. According to the American Cancer Society (ACS), there were roughly 9,270 cancer deaths among adolescents and young adults in the U.S. in 2019 who were between the ages of 15 and 39, and there were about 89,500 new cases of cancer diagnosed in 2020. These factors would drive market growth.

The COVID-19 pandemic had a positive effect on the market. For instance, in August 2020, research published in Springer discovered that flow cytometry analysis of peripheral blood mononuclear cell (PBMC) phenotype helped to predict the risk of COVID-19 clinical progression and indicated that improved antigen presentation and more effective adaptive immune responses are associated with recovery from COVID-19. The increasing frequency of infectious and chronic disorders, most notably the COVID-19 outbreak, has increased the need for technology for study and diagnosis, supporting the market's growth.

Furthermore, the U.S. has a robust healthcare infrastructure, significant healthcare spending, and widespread usage of highly advanced flow cytometry technologies. In addition, owing to research universities engaging in a wide range of research activities and having developed pharmaceutical enterprises, there is an enormous need for flow cytometry workflow for research purposes. This results from the U.S.'s substantial investment in healthcare, highly developed healthcare infrastructure, and widespread usage of cutting-edge flow cytometry technology.

U.S. Flow Cytometry Market Report Highlights

Based on product, instrument dominated the market and accounted for 35.08% in 2023. Flow cytometry instruments are crucial in clinical diagnostics for applications such as immunophenotyping cells to monitor HIV/AIDS progression, detect minimal residual disease in leukemia, and assess immune cell function, which will fuel the segment growth
In terms of technology, the cell-based segment dominated the market share in 2023. This technology involves analyzing cells based on their characteristics, such as size, complexity, and the presence of specific molecules. On the other hand, the bead-based segment is expected to grow at the fastest CAGR over the forecast period
Based on application, the clinical segment held the largest market share in 2023. The industrial segment is expected to grow fastest over the forecast period
In terms of end-use, the academic institute segment held the largest market share in 2023. Clinical testing labsare anticipated to witness the fastest growth over the forecast period
The U.S. is the major dominating country in the market due to the surging incidence rate of diseases such as cancer and HIV amongst the population in this country, which is boosting the demand for U.S. flow cytometry market
In January 2024, Sony Biotechnology launched the EC800, a highly versatile flow cytometry analyzer. This innovative device caters to various applications, such as particle sizing, immunophenotyping, cell viability, absolute cell counting, and apoptosis detection, among others. The EC800 offers cost-effective solutions suitablefor diverse research and diagnostic needs.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. End-use
1.2.5. Region
1.2.6. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Volume Price Analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Technology Outlook
2.2.3. Application Outlook
2.2.4. End-use Outlook
2.2.5. Regional Outlook
2.3. Competitive Insights

Chapter 3. U.S. Flow Cytometry Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. Flow Cytometry Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape

Chapter 4. U.S. Flow Cytometry Market: Product Estimates & Trend Analysis

4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Flow Cytometry Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Instruments
4.4.1.1. Market Estimates and Forecasts 2018-2030 (USD Million)
4.4.1.2. Cell Analyzers
4.4.1.2.1. Market Estimates and Forecasts 2018-2030 (USD Million)
4.4.1.3. Cell Sorters
4.4.1.3.1. Market Estimates and Forecasts 2018-2030 (USD Million)
4.4.2. Reagents & Consumables
4.4.2.1. Market Estimates and Forecasts 2018-2030 (USD Million)
4.4.3. Software
4.4.3.1. Market Estimates and Forecasts 2018-2030 (USD Million)
4.4.4. Accessories
4.4.4.1. Market Estimates and Forecasts 2018-2030 (USD Million)
4.4.5. Services
4.4.5.1. Market Estimates and Forecasts 2018-2030 (USD Million)

Chapter 5. U.S. Flow Cytometry Market: Technology Estimates & Trend Analysis

5.1. Technology Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Flow Cytometry Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Cell-based
5.4.1.1. Market Estimates and Forecasts 2018-2030 (USD Million)
5.4.2. Bead-based
5.4.2.1. Market Estimates and Forecasts 2018-2030 (USD Million)

Chapter 6. U.S. Flow Cytometry Market: Application Estimates & Trend Analysis

6.1. Application Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Flow Cytometry Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Research
6.4.1.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.1.2. Pharmaceutical
6.4.1.2.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.1.2.2. Drug Discovery
6.4.1.2.2.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.1.2.3. In Vitro Toxicity
6.4.1.2.3.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.1.2.4. Stem Cell
6.4.1.2.4.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.1.3. Apoptosis
6.4.1.3.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.1.4. Cell Sorting
6.4.1.4.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.1.5. Cell Cycle Analysis
6.4.1.5.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.1.6. Immunology
6.4.1.6.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.1.7. Cell Viability
6.4.1.7.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.2. Industrial
6.4.2.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.3. Clinical
6.4.3.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.3.2. Cancer
6.4.3.2.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.3.3. Organ Transplantation
6.4.3.3.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.3.4. Immunodeficiency
6.4.3.4.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.3.5. Hematology
6.4.3.5.1. Market Estimates and Forecasts 2018-2030 (USD Million)
6.4.3.6. Autoimmune Disorders
6.4.3.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Flow Cytometry Market: End-use Estimates & Trend Analysis

7.1. End-use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. U.S. Flow Cytometry Market by End-use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.4.1. Clinical Testing Labs
7.4.1.1. Market Estimates and Forecasts 2018-2030 (USD Million)
7.4.2. Academic Institutes
7.4.2.1. Market Estimates and Forecasts 2018-2030 (USD Million)
7.4.3. Commercial Organizations
7.4.3.1. Market Estimates and Forecasts 2018-2030 (USD Million)
7.4.3.2. Biotechnology Companies
7.4.3.2.1. Market Estimates and Forecasts 2018-2030 (USD Million)
7.4.3.3. Pharmaceutical Companies
7.4.3.3.1. Market Estimates and Forecasts 2018-2030 (USD Million)
7.4.3.4. CROs
7.4.3.4.1. Market Estimates and Forecasts 2018-2030 (USD Million)
7.4.4. Hospitals
7.4.4.1. Market Estimates and Forecasts 2018-2030 (USD Million)

Chapter 8. U.S. Flow Cytometry Market: Region Estimates & Trend Analysis

8.1. Regional Market Share, 2023 & 2030
8.2. U.S. Flow Cytometry Market by Regional Outlook
8.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
8.3.1. West
8.3.1.1. Market Estimates and Forecasts 2018-2030 (USD Million)
8.3.2. Midwest
8.3.2.1. Market Estimates and Forecasts 2018-2030 (USD Million)
8.3.3. Northeast
8.3.3.1. Market Estimates and Forecasts 2018-2030 (USD Million)
8.3.4. Southwest
8.3.4.1. Market Estimates and Forecasts 2018-2030 (USD Million)
8.3.5. Southeast
8.3.5.1. Market Estimates and Forecasts 2018-2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of Key Distributors and Channel Partners
9.3.2. Key Customers
9.3.3. Key Company Heat Map Analysis, 2023
9.4. Company Profiles
9.4.1. Sysmex Corp
9.4.1.1. Company Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Becton, Dickinson, and Company (B.D.)
9.4.2.1. Company Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Danaher Corp
9.4.3.1. Company Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Thermo Fisher Scientific, Inc.
9.4.4.1. Company Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Agilent Technologies, Inc.
9.4.5.1. Company Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Bio-Rad Laboratories, Inc.
9.4.6.1. Company Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Sony Biotechnology, Inc.
9.4.7.1. Company Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Beckman Coulter, Inc.
9.4.8.1. Company Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Cytek Biosciences
9.4.9.1. Company Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. BioLegend, Inc.
9.4.10.1. Company Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Enzo Biochem Inc.
9.4.11.1. Company Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. Cell Signaling Technology, Inc.
9.4.12.1. Company Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Strategic Initiatives
9.4.13. NeoGenomics Laboratories
9.4.13.1. Company Overview
9.4.13.2. Financial Performance
9.4.13.3. Product Benchmarking
9.4.13.4. Strategic Initiatives
9.4.14. Q2 Solutions (IQVIA)
9.4.14.1. Company Overview
9.4.14.2. Financial Performance
9.4.14.3. Product Benchmarking
9.4.14.4. Strategic Initiatives
9.4.15. Elabscience Biotechnology Inc.
9.4.15.1. Company Overview
9.4.15.2. Financial Performance
9.4.15.3. Product Benchmarking
9.4.15.4. Strategic Initiatives
9.4.16. Stratedigm, Inc.
9.4.16.1. Company Overview
9.4.16.2. Financial Performance
9.4.16.3. Product Benchmarking
9.4.16.4. Strategic Initiatives
9.4.17. BioLegend, Inc.
9.4.17.1. Company Overview
9.4.17.2. Financial Performance
9.4.17.3. Product Benchmarking
9.4.17.4. Strategic Initiatives
9.4.18. Union Biometrica, Inc.
9.4.18.1. Company Overview
9.4.18.2. Financial Performance
9.4.18.3. Product Benchmarking
9.4.18.4. Strategic Initiatives
9.4.19. BennuBio Inc.
9.4.19.1. Company Overview
9.4.19.2. Financial Performance
9.4.19.3. Product Benchmarking
9.4.19.4. Strategic Initiatives
9.4.20. ORLFO Technologies
9.4.20.1. Company Overview
9.4.20.2. Financial Performance
9.4.20.3. Product Benchmarking
9.4.20.4. Strategic Initiativesw

List of Tables

Table 1 List of Abbreviations
Table 2 List of Secondary Sources
Table 3 U.S. Flow Cytometry Market by Product, 2018-2030 (USD Million)
Table 4 U.S. Flow Cytometry Market by Technology, 2018-2030 (USD Million)
Table 5 U.S. Flow Cytometry Market by Application, 2018-2030 (USD Million)
Table 6 U.S. Flow Cytometry Market by End-use, 2018-2030 (USD Million)
Table 7 U.S. Flow Cytometry Market by Region, 2018-2030 (USD Million)

List of Figures

Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-chain-based Sizing & Forecasting
Figure 6 QFD Modeling for Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 U.S. Flow Cytometry Market: Market Outlook
Figure 9 U.S. Flow Cytometry Competitive Insights
Figure 10 Parent Market Outlook
Figure 11 Related/ancillary Market Outlook
Figure 12 Penetration and Growth Prospect Mapping
Figure 13 Industry Value Chain Analysis
Figure 14 U.S. Flow Cytometry Market Driver Impact
Figure 15 U.S. Flow Cytometry Market Restraint Impact
Figure 16 U.S. Flow Cytometry Market Strategic Initiatives Analysis
Figure 17 U.S. Flow Cytometry Market: Product Movement Analysis
Figure 18 U.S. Flow Cytometry Market: Product Outlook and Key Takeaways
Figure 19 Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 20 Cell Analyzers Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 21 Cell Sorters Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Reagents & Consumables Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Software Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 Accessories Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 U.S. Flow Cytometry Market: Technology Movement Analysis
Figure 27 U.S. Flow Cytometry Market: Technology Outlook and Key Takeaways
Figure 28 Cell-based Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 Bead-based Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 30 U.S. Flow Cytometry Market: Application Movement Analysis
Figure 31 U.S. Flow Cytometry Market: Application Outlook and Key Takeaways
Figure 32 Research Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Pharmaceutical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Drug Discovery Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 in Vitro Toxicity Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Stem Cell Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 37 Apoptosis Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 Cell Sorting Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Cell Cycle Analysis Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Immunology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Cell Viability Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Industrial Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 Organ Transplantation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Immunodeficiency Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Hematology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 48 Autoimmune Disorders Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 U.S. Flow Cytometry Market: End-use Movement Analysis
Figure 50 U.S. Flow Cytometry Market: End-use Outlook and Key Takeaways
Figure 51 Clinical Testing Labs Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Academic Institutes Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Commercial Organizations Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 54 Biotechnology Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Pharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 56 CROs Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Hospitals Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 58 U.S. Flow Cytometry Market: Regional Movement Analysis
Figure 59 U.S. Flow Cytometry Market: Regional Outlook and Key Takeaways
Figure 60 West Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Midwest Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 Northeast Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 Southwest Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 Southeast Market Estimates and Forecasts, 2018-2030 (USD Million)

Companies Mentioned

Sysmex Corp
Becton, Dickinson, and Company (B.D.)
Danaher Corp
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Sony Biotechnology, Inc.
Beckman Coulter, Inc.
Cytek Biosciences
BioLegend, Inc.
Enzo Biochem Inc.
Cell Signaling Technology, Inc.
NeoGenomics Laboratories
Q2 Solutions (IQVIA)
Elabscience Biotechnology Inc.
Stratedigm, Inc.
BioLegend, Inc.
Union Biometrica, Inc.
BennuBio Inc.
ORLFO Technologies

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	70
Published	May 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 1.61 Billion
Forecasted Market Value ( USD ) by 2030	$ 2.61 Billion
Compound Annual Growth Rate	6.8%
Regions Covered	United States
No. of Companies Mentioned	20

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3876EUR$3,950USD£3,223GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€4857EUR$4,950USD£4,039GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€6819EUR$6,950USD£5,671GBP

U.S. Flow Cytometry Market Size, Share & Trends Analysis Report by Product (Software, Accessories), Technology (Cell-based, Bead-based), Application, End-use, Region, and Segment Forecasts, 2024-2030

U.S. Flow Cytometry Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

U.S. Flow Cytometry Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Flow Cytometry Market Size, Share & Trends Analysis Report by Product (Instruments, Software), Technology (Bead-based, Cell-based), Application (Industrial, Clinical), End-use, Region, and Segment Forecasts, 2024-2030

Flow Cytometry Market by Product & Service, Technology, Application, End-User - Global Forecast 2025-2030

Flow Cytometry in Oncology & Immunology Market by Type, Technology, Product & Service, End User - Global Forecast 2025-2030

Flow Cytometry in Oncology and Immunology Global Market Report 2024

Flow Cytometry Market Size and Forecasts 2024-2034: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

About the Flow Cytometry Market